Pharmaceuticals & Therapeutics

Aardvark Therapeutics is expanding its Phase 3 trial for a novel Prader-Willi Syndrome drug to include children as young as seven, targeting a key unmet need.

As Milestone Pharma launches its novel, self-administered heart drug CARDAMYST, it hires a legal expert to navigate the high-stakes commercial rollout.

Ahead of its first Climate Week, Mumbai's food innovators and activists gather to debate a sustainable future, proving the fight for the planet begins on our plates.

A new low-risk rental program from Alfa Laval lets ethanol producers boost valuable corn oil yields without the massive upfront cost of new equipment.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

Swiss pharma Santhera appoints Stifel as advisor, a strategic move to fuel the global rollout of its DMD drug AGAMREE amid a complex biotech funding market.

While California's cannabis market declined, MWG Holdings hit record revenues by focusing on community, innovation, and strategic growth. Here's how.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

With transplant patient needs growing, BioMatrix promotes Heidi Ulbrich to manage its services, highlighting a model built for speed and complex care.

The nation's top IV therapy franchise reports record growth, but its expansion highlights a booming wellness industry navigating a complex regulatory landscape.

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

A landmark deal will see Takeda use Iambic's AI platform to slash drug development timelines and fast-track new medicines for cancer and other diseases.

A £500,000 philanthropic investment fuels five pioneering research projects at Oxford, aiming to unlock new treatments for a devastating rare disease.

A new technical report reveals an 85% IRR for the Arraias project, positioning Itafos to tap into Brazil's huge domestic fertilizer market.

A new German partnership aims to create variant-ready, room-temperature stable vaccines, moving beyond the limits of first-generation mRNA technology.

The deal marks the final step in a major strategic overhaul for dsm-firmenich, which will now focus solely on its nutrition, health, and beauty businesses.

A national scholarship founded by a top neurosurgeon invests in students poised to solve healthcare’s biggest challenges, addressing critical workforce shortages.

A new federal grant positions Curio's NuCycle technology to tackle nuclear waste, promising a cleaner, more sustainable American energy future.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.